| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |